Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial
For a healthcare provider, thats a massive red flag
It may be appropriate to reassess your plan if any of the following occur
Participants in Phase 2 trials demonstrated significant decreases in waist circumference that exceeded what would be expected from total weight loss alone, suggesting the compound specifically targets this problematic fat depot
The limited human data available indicate that both peptides appear to be generally well-tolerated, yet comprehensive safety and efficacy assessments from large, well-designed clinical trials are absent
May Support the Immune System May Relieve Certain Respiratory Symptoms Some evidence suggests that delivering intravenous (IV) glutathione may relieve shortness of breath associated with COVID-19 and COVID-19 pneumonia (a lung infection caused by the SARS-COV-2 virus)